Calcium ascorbate and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium ascorbate (vitamin c (ascorbic acid)) and Ondansetron (ondansetron). Common drug interactions include decreased appetite among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium ascorbate and Ondansetron. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium ascorbate?

Calcium ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 1,018 Calcium ascorbate users. Check the latest studies of Calcium ascorbate.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,739 Ondansetron users. Check the latest studies of Ondansetron.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

39 people who take Calcium ascorbate and Ondansetron together, and have interactions are studied.

Calcium ascorbate and Ondansetron drug interactions.

What are the common drug interactions of Calcium Ascorbate and Ondansetron, by gender? *:

female:

Decreased appetite
Malaise (a feeling of general discomfort or uneasiness)
Concussion (short loss of normal brain function in response to a head injury)
Fatigue (feeling of tiredness)
Abdominal pain upper
Back pain
Cellulitis (infection under the skin)
Fall
Feeding disorder (when children refuse to eat certain food groups)
Head injury

male:

Abdominal distension
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Disease progression
Leukopenia (less number of white blood cells in blood)
Neuropathy peripheral (surface nerve damage)
Non-alcoholic steatohepatitis (liver inflammation caused by a build up of fat in the liver)
Pulmonary embolism (blockage of the main artery of the lung)
Fall
Pathological fracture (broken bone caused by disease)
Plasma cell myeloma (cancer that begins in plasma cells)

What are the common drug interactions of Calcium Ascorbate and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Adjustment disorder with mixed anxiety and depressed mood
Anxiety
Concussion (short loss of normal brain function in response to a head injury)
Depressed mood
Hypermobility syndrome (abnormalities cause abnormal stress on a joint or many joint)
Loss of consciousness
Migraine with aura (headache with vision weakness)
Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

30-39:

n/a

40-49:

n/a

50-59:

Neuropathy peripheral (surface nerve damage)
Platelet count decreased

60+:

Abdominal distension
Decreased appetite
Head injury
Infusion related reaction
Pyrexia (fever)
Sinus disorder (disease of sinus)
Weight increased
Alopecia (absence of hair from areas of the body)
Diarrhoea
Abdominal pain

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 20.51%
High Blood Cholesterol: 7 people, 17.95%
Constipation: 6 people, 15.38%
Multiple Myeloma (cancer of the plasma cells): 6 people, 15.38%
Diabetes: 6 people, 15.38%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 12.82%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 12.82%
Pain: 5 people, 12.82%
Dyspnea (difficult or laboured breathing): 4 people, 10.26%
Ventricular Fibrillation (abnormally irregular heart rhythm): 4 people, 10.26%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium ascorbate and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously